LLY - Verve drops after pausing enrollments in trial for lead asset April, 02 2024 07:34 AM Eli Lilly and Company 2024-04-02 07:34:50 ET More on Verve Therapeutics Verve's Proof-Of-Concept Data Doesn't Inspire Confidence Vectoring In On Verve Therapeutics Seeking Alpha’s Quant Rating on Verve Therapeutics Historical earnings data for Verve Therapeutics Financial information for Verve Therapeutics For further details see: Verve drops after pausing enrollments in trial for lead asset